Literature DB >> 21441505

The Moraxella catarrhalis nitric oxide reductase is essential for nitric oxide detoxification.

Wei Wang1, Traci Kinkel, Willm Martens-Habbena, David A Stahl, Ferric C Fang, Eric J Hansen.   

Abstract

Moraxella catarrhalis is a Gram-negative obligate aerobe that is an important cause of human respiratory tract infections. The M. catarrhalis genome encodes a predicted truncated denitrification pathway that reduces nitrate to nitrous oxide. We have previously shown that expression of both the M. catarrhalis aniA (encoding a nitrite reductase) and norB (encoding a putative nitric oxide reductase) genes is repressed by the transcriptional regulator NsrR under aerobic conditions and that M. catarrhalis O35E nsrR mutants are unable to grow in the presence of low concentrations of nitrite (W. Wang, et al., J. Bacteriol. 190:7762-7772, 2008). In this study, we constructed an M. catarrhalis norB mutant and showed that planktonic growth of this mutant is inhibited by low levels of nitrite, whether or not an nsrR mutation is present. To determine the importance of NorB in this truncated denitrification pathway, we analyzed the metabolism of nitrogen oxides by norB, aniA norB, and nsrR norB mutants. We found that norB mutants are unable to reduce nitric oxide and produce little or no nitrous oxide from nitrite. Furthermore, nitric oxide produced from nitrite by the AniA protein is bactericidal for a Moraxella catarrhalis O35E norB mutant but not for wild-type O35E bacteria under aerobic growth conditions in vitro, suggesting that nitric oxide catabolism in M. catarrhalis is accomplished primarily by the norB gene product. Measurement of bacterial protein S-nitrosylation directly implicates nitrosative stress resulting from AniA-dependent nitric oxide formation as a cause of the growth inhibition of norB and nsrR mutants by nitrite.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441505      PMCID: PMC3133116          DOI: 10.1128/JB.00139-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  74 in total

1.  Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins.

Authors:  S Jourdain; P R Smeesters; O Denis; M Dramaix; V Sputael; X Malaviolle; L Van Melderen; A Vergison
Journal:  Clin Microbiol Infect       Date:  2010-12-14       Impact factor: 8.067

2.  Community-acquired Moraxella catarrhalis pneumonia in previously healthy children.

Authors:  Magdalena G Sy; Joan L Robinson
Journal:  Pediatr Pulmonol       Date:  2010-07

3.  Anaerobic metabolism occurs in the substratum of gonococcal biofilms and may be sustained in part by nitric oxide.

Authors:  Megan L Falsetta; Alastair G McEwan; Michael P Jennings; Michael A Apicella
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

4.  Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae.

Authors:  Suzanne J C Verhaegh; Martine L Snippe; Foster Levy; Henri A Verbrugh; Vincent W V Jaddoe; Albert Hofman; Henriëtte A Moll; Alex van Belkum; John P Hays
Journal:  Microbiology       Date:  2010-09-16       Impact factor: 2.777

5.  Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling.

Authors:  Chelsie E Armbruster; Wenzhou Hong; Bing Pang; Kristin E D Weimer; Richard A Juneau; James Turner; W Edward Swords
Journal:  MBio       Date:  2010-07-06       Impact factor: 7.867

6.  Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease.

Authors:  Grant A Mackenzie; Amanda J Leach; Jonathan R Carapetis; Janelle Fisher; Peter S Morris
Journal:  BMC Infect Dis       Date:  2010-10-23       Impact factor: 3.090

7.  Biochemical and genomic analysis of the denitrification pathway within the genus Neisseria.

Authors:  Kenneth R Barth; Vincent M Isabella; Virginia L Clark
Journal:  Microbiology (Reading)       Date:  2009-09-17       Impact factor: 2.777

8.  Nitrite reductase NirS is required for type III secretion system expression and virulence in the human monocyte cell line THP-1 by Pseudomonas aeruginosa.

Authors:  Nadine E Van Alst; Melanie Wellington; Virginia L Clark; Constantine G Haidaris; Barbara H Iglewski
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

Review 9.  Moraxella catarrhalis bacteraemia associated with prosthetic vascular graft infection.

Authors:  Naoto Sano; Satoshi Matsunaga; Tomonori Akiyama; Yukari Nakashima; Koji Kusaba; Zenzo Nagasawa; Shunzo Koizumi; Masaaki Goto; Hiroshi Miyamoto
Journal:  J Med Microbiol       Date:  2009-10-22       Impact factor: 2.472

10.  Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis.

Authors:  Jay R Laver; Tânia M Stevanin; Sarah L Messenger; Amy Dehn Lunn; Margaret E Lee; James W B Moir; Robert K Poole; Robert C Read
Journal:  FASEB J       Date:  2009-08-31       Impact factor: 5.191

View more
  11 in total

Review 1.  Nitrate, nitrite and nitric oxide reductases: from the last universal common ancestor to modern bacterial pathogens.

Authors:  Andrés Vázquez-Torres; Andreas J Bäumler
Journal:  Curr Opin Microbiol       Date:  2015-09-29       Impact factor: 7.934

Review 2.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

3.  An essential role for bacterial nitric oxide synthase in Staphylococcus aureus electron transfer and colonization.

Authors:  Traci L Kinkel; Smirla Ramos-Montañez; Jasmine M Pando; Daniel V Tadeo; Erin N Strom; Stephen J Libby; Ferric C Fang
Journal:  Nat Microbiol       Date:  2016-11-28       Impact factor: 17.745

4.  Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis.

Authors:  Todd C Hoopman; Wei Liu; Stephanie N Joslin; Christine Pybus; Jennifer L Sedillo; Maria Labandeira-Rey; Cassie A Laurence; Wei Wang; James A Richardson; Lauren O Bakaletz; Eric J Hansen
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

5.  Bacterium-generated nitric oxide hijacks host tumor necrosis factor alpha signaling and modulates the host cell cycle in vitro.

Authors:  Brian Mocca; Wei Wang
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

6.  Development of a LacZ-based transcriptional reporter system for use with Moraxella catarrhalis.

Authors:  Amanda S Evans; Christine Pybus; Eric J Hansen
Journal:  Plasmid       Date:  2012-12-04       Impact factor: 3.466

Review 7.  Antimicrobial actions of reactive oxygen species.

Authors:  Ferric C Fang
Journal:  MBio       Date:  2011-09-06       Impact factor: 7.867

8.  Ralstonia solanacearum uses inorganic nitrogen metabolism for virulence, ATP production, and detoxification in the oxygen-limited host xylem environment.

Authors:  Beth L Dalsing; Alicia N Truchon; Enid T Gonzalez-Orta; Annett S Milling; Caitilyn Allen
Journal:  MBio       Date:  2015-03-17       Impact factor: 7.867

9.  The Moraxella catarrhalis phase-variable DNA methyltransferase ModM3 is an epigenetic regulator that affects bacterial survival in an in vivo model of otitis media.

Authors:  Luke V Blakeway; Aimee Tan; Joseph A Jurcisek; Lauren O Bakaletz; John M Atack; Ian R Peak; Kate L Seib
Journal:  BMC Microbiol       Date:  2019-12-09       Impact factor: 3.605

10.  The NarX-NarL two-component system regulates biofilm formation, natural product biosynthesis, and host-associated survival in Burkholderia pseudomallei.

Authors:  Mihnea R Mangalea; Bradley R Borlee
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.